{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:06:06Z","timestamp":1772294766012,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Research Foundation (DFG) Collaborative Research Center SFB969"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.molimm.2019.02.010","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T10:08:20Z","timestamp":1551089300000},"page":"111-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The ubiquitin-like modifier FAT10 is required for normal IFN-\u03b3 production by activated CD8+ T cells"],"prefix":"10.1016","volume":"108","author":[{"given":"Mei Min","family":"Mah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Basler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus","family":"Groettrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.02.010_bib0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.biocel.2016.07.001","article-title":"The ubiquitin-like modifier FAT10 in cancer development","volume":"79","author":"Aichem","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ncomms1012","article-title":"USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis","volume":"1","author":"Aichem","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2019.02.010_bib0015","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1242\/jcs.107789","article-title":"The proteomic analysis of endogenous FAT10 substrates identifies p62\/SQSTM1 as a substrate of FAT10ylation","volume":"125","author":"Aichem","year":"2012","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.molimm.2019.02.010_bib0020","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.4049\/jimmunol.0901596","article-title":"The proteasome inhibitor bortezomib enhances the susceptibility to viral infection","volume":"183","author":"Basler","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0025","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/eji.1830271002","article-title":"Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells","volume":"27","author":"Bates","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.molimm.2017.01.019","article-title":"Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-kappaB activation","volume":"83","author":"Bitzer","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0035","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1128\/MCB.00966-05","article-title":"FAT10\/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences","volume":"26","author":"Canaan","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0040","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1073\/pnas.1323426111","article-title":"Extended lifespan and reduced adiposity in mice lacking the FAT10 gene","volume":"111","author":"Canaan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.010_bib0045","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.molonc.2014.01.007","article-title":"NFkappaB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53","volume":"8","author":"Choi","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0050","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.192.12.1685","article-title":"CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo","volume":"192","author":"den Haan","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2019.02.010_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02660056","article-title":"Identification of seven new human MHC class I region genes around the HLA-F locus","volume":"44","author":"Fan","year":"1996","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2019.02.010_bib0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.iy.11.040193.003035","article-title":"The molecular cell biology of interferon-\u03b3 and its receptor","volume":"11","author":"Farrar","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0065","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1471-4906(01)02005-1","article-title":"IFN-gamma production by antigen-presenting cells: mechanisms emerge","volume":"22","author":"Frucht","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0070","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1681\/ASN.2009050479","article-title":"The ubiquitin-like protein FAT10 mediates NF-kappa B activation","volume":"21","author":"Gong","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0075","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2015.08.019","article-title":"Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease","volume":"216","author":"Herrmann","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.molimm.2019.02.010_bib0080","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1128\/MCB.25.9.3483-3491.2005","article-title":"FAT10, a ubiquitin-independent signal for proteasomal degradation","volume":"25","author":"Hipp","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0085","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-\u03b3 receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.010_bib0090","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nature05902","article-title":"Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging","volume":"447","author":"Jin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2019.02.010_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"K\u00e4gi","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2019.02.010_bib0100","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/sj.onc.1206337","article-title":"Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers","volume":"22","author":"Lee","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2019.02.010_bib0105","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1073\/pnas.96.8.4313","article-title":"A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.02.010_bib0110","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1038\/onc.2008.201","article-title":"Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon","volume":"27","author":"Lukasiak","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.molimm.2019.02.010_bib0115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2013.02.007","article-title":"Profiling of ubiquitin-like modifications reveals features of mitotic control","volume":"152","author":"Merbl","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2019.02.010_bib0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/76940","article-title":"Interferon \u03b1\/\u03b2-mediated inhibition and promotion of interferon-\u03b3: STATI resolves a paradox","volume":"1","author":"Nguyen","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/oxfordjournals.bmb.a072029","article-title":"Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis","volume":"41","author":"Oldstone","year":"1985","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.molimm.2019.02.010_bib0130","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.4049\/jimmunol.156.3.1138","article-title":"An absolute and restricted requirement for IL-12 in natural killer cell IFN-\u03b3 production and antiviral defense","volume":"156","author":"Orange","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0135","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1128\/JVI.75.18.8407-8423.2001","article-title":"Critical role for alpha\/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells","volume":"75","author":"Ou","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0140","doi-asserted-by":"crossref","first-page":"23010","DOI":"10.1074\/jbc.C700111200","article-title":"UBE1L2, a novel E1 enzyme specific for ubiquitin","volume":"282","author":"Pelzer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.02.010_bib0145","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.molimm.2019.02.010_bib0150","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<4030::AID-IMMU4030>3.0.CO;2-Y","article-title":"A ubiquitin-like protein which is synergistically inducible by interferon-\u03b3 and tumor necrosis factor-\u03b1","volume":"29","author":"Raasi","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0155","doi-asserted-by":"crossref","first-page":"35334","DOI":"10.1074\/jbc.M105139200","article-title":"The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis","volume":"276","author":"Raasi","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.02.010_bib0160","doi-asserted-by":"crossref","first-page":"11413","DOI":"10.1074\/jbc.M507218200","article-title":"FAT10 plays a role in the regulation of chromosomal stability","volume":"281","author":"Ren","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2019.02.010_bib0165","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1242\/jcs.087403","article-title":"FAT10 mediates the effect of TNF-alpha in inducing chromosomal instability","volume":"124","author":"Ren","year":"2011","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.molimm.2019.02.010_bib0170","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1681\/ASN.2005070692","article-title":"Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease","volume":"17","author":"Ross","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bbamcr.2013.01.009","article-title":"FAT10ylation as a signal for proteasomal degradation","volume":"1843","author":"Schmidtke","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molimm.2019.02.010_bib0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00251-018-1055-5","article-title":"The expression profile of the ubiquitin-like modifier FAT10 in immune cells suggests cell type-specific functions","volume":"70","author":"Schregle","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/j.molimm.2019.02.010_bib0185","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","article-title":"Viruses and interferons","volume":"55","author":"Sen","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0190","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1242\/jcs.152371","article-title":"The ubiquitin-like modifier FAT10 decorates autophagy-targeted Salmonella and contributes to Salmonella resistance in mice","volume":"127","author":"Spinnenhirn","year":"2014","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.molimm.2019.02.010_bib0195","doi-asserted-by":"crossref","first-page":"e01978","DOI":"10.1128\/mBio.01978-14","article-title":"CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection","volume":"5","author":"Suarez-Ramirez","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.molimm.2019.02.010_bib0200","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.010_bib0205","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/JVI.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"van den Broek","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2019.02.010_bib0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.molimm.2019.02.010_bib0215","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4049\/jimmunol.1501563","article-title":"FAT10 is critical in influenza A virus replication by inhibiting type I IFN","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018308666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018308666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T22:37:00Z","timestamp":1694644620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018308666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":43,"alternative-id":["S0161589018308666"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.02.010","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ubiquitin-like modifier FAT10 is required for normal IFN-\u03b3 production by activated CD8+ T cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}